Phase 4CompletedINTERVENTIONAL
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
ClinicalTrials.gov · NCT00502138 · Registry updated: 2013-01-16
- Condition / research focus
- IDDM
- Sponsor
- University Diabetes & Endocrine Consultants
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2007-07. Completion: 2008-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Continuous Pramlintide infusion (drug) — also listed as: pramlintide
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University Diabetes & Endocrine Consultants
Chattanooga, Tennessee, United States
Site recruitment: Not reported